Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Dermatol ; 35(4): e231-e232, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29633329

RESUMO

Apocrine hidrocystomas are mostly found on the cheeks and eyelids but also on the scalp and neck. The age distribution is from 30 to 70 years old. We report a case of an apocrine hidrocystoma on the genitalia of a 9-year-old girl.


Assuntos
Genitália/patologia , Hidrocistoma/patologia , Neoplasias das Glândulas Sudoríparas/patologia , Criança , Diagnóstico Diferencial , Feminino , Humanos
2.
Tokai J Exp Clin Med ; 39(1): 5-9, 2014 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-24733591

RESUMO

A 73-year-old male with diabetes mellitus had been treated with insulin for six years. He developed a solid mass on his left lateral of the abdomen at the insulin injection site. A firm subcutaneous mass with dark-red erythema was overlaid by dark-brown keratinized plaques. On histological examination of the mass, keratin proliferation and epidermal papilloma were observed. There were four previously reported cases of acanthosis nigricans that were considered to be caused by continuous injections of insulin. Using immunohistochemistry, in our case the findings were positive in the basal epithelial and prickle cell layers when the patient's lesion was dyed with insulin-like growth factor (IGF)-1 antibody. The coexistence of dermal IGF-1 receptor and acanthosis nigricans found in our patient has not been reported previously, to our knowledge.


Assuntos
Acantose Nigricans/induzido quimicamente , Acantose Nigricans/patologia , Insulina/administração & dosagem , Insulina/efeitos adversos , Acantose Nigricans/metabolismo , Idoso , Humanos , Injeções Subcutâneas , Masculino , Receptor IGF Tipo 1/metabolismo
3.
J Dermatol ; 40(4): 238-43, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23330814

RESUMO

Various therapies have been tried for psoriasis. In Japan, biologics began to be used for psoriasis treatment in January 2010. Their clinical efficacy is well known, but biologics cannot be used in all psoriasis patients for reasons such as side-effects and cost. It is necessary to evaluate the effect of long-term psoriasis treatment, but there have been no reports evaluating long-term treatment. Therefore, the outcomes of patients who had been treated at the Tokai University Hospital for more than 5 years, before biological agents were released, were examined. Three categories, classified by initial severity, changes in severity by method of treatment and background characteristics, were investigated. In conclusion, cases of long-term treatment with a combination of topical corticosteroid and topical vitamin D3 analog or oral cyclosporin were found to be effective therapies. Patients with a history of diabetes mellitus or cardiovascular disease of psoriasis were likely to be treatment resistant.


Assuntos
Colecalciferol/uso terapêutico , Ciclosporina/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Etretinato/uso terapêutico , Glucocorticoides/uso terapêutico , Fototerapia/métodos , Psoríase/tratamento farmacológico , Administração Oral , Administração Tópica , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Colecalciferol/efeitos adversos , Colecalciferol/análogos & derivados , Ciclosporina/efeitos adversos , Fármacos Dermatológicos/efeitos adversos , Combinação de Medicamentos , Etretinato/efeitos adversos , Feminino , Seguimentos , Glucocorticoides/efeitos adversos , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
4.
Tokai J Exp Clin Med ; 37(1): 6-10, 2012 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-22488556

RESUMO

Chromomycosis is a chronic fungal disease of the skin and subcutaneous tissues caused by a group of dematiaceous black fungi. Small lesions can be removed with excision, but other cases are difficult to treat. We report a case of chromomycosis caused by Fonsecaea pedrosoi (F. pedrosoi). The case involved a 74-year-old man, who had noted a lesion on the back of the right thigh, that was gradually enlarging and reaching up to 30 cm in diameter, in 20-years. From microscopic examination, sclerotic cells were seen. We diagnosed this case as chromomycosis caused by F. pedrosoi on mycological examination. The patient was initially treated with oral terbinafine (250 mg/day) as the lesion was very large. After the 18 months treatment, the size of the lesion reduced to 1 cm, then the remaining lesion was excised.


Assuntos
Antifúngicos/uso terapêutico , Cromoblastomicose , Naftalenos/uso terapêutico , Idoso , Antifúngicos/administração & dosagem , Ascomicetos/isolamento & purificação , Cromoblastomicose/tratamento farmacológico , Cromoblastomicose/microbiologia , Cromoblastomicose/cirurgia , Terapia Combinada , Humanos , Masculino , Naftalenos/administração & dosagem , Terbinafina , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...